|
Pronunciation |
|
(zye
loe met AZ oh
leen) |
|
|
U.S. Brand
Names |
|
Otrivin® Nasal
[OTC] |
|
|
Generic
Available |
|
Yes |
|
|
Synonyms |
|
Xylometazoline Hydrochloride |
|
|
Pharmacological Index |
|
Ophthalmic Agent, Vasoconstrictor |
|
|
Use |
|
Symptomatic relief of nasal and nasopharyngeal mucosal
congestion |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Adverse
Reactions |
|
1% to 10%:
Central nervous system: Drowsiness, dizziness, seizures, headache
Ocular: Blurred vision, ocular irritation, photophobia
Miscellaneous: Sweating |
|
|
Drug
Interactions |
|
No data reported |
|
|
Mechanism of
Action |
|
Stimulates alpha-adrenergic receptors in the arterioles of the conjunctiva
and the nasal mucosa to produce vasoconstriction |
|
|
Pharmacodynamics/Kinetics |
|
Onset of action: Intranasal: Local vasoconstriction occurs within 5-10
minutes
Duration: 5-6 hours |
|
|
Usual Dosage |
|
Children 2-12 years: Instill 2-3 drops (0.05%) in each nostril every 8-10
hours
Children >12 years and Adults: Instill 2-3 drops or sprays (0.1%) in each
nostril every 8-10 hours |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
Do not exceed recommended dosage; do not use for more than 4 consecutive
days |
|
|
Nursing
Implications |
|
Do not exceed recommended dosage; do not use for more than 4 consecutive
days |
|
|
Dosage Forms |
|
Solution, nasal, as hydrochloride: 0.05% [0.5 mg/mL] (20 mL); 0.1% [1 mg/mL]
(15 mL, 20 mL) |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|